Sodium-glucose cotransporter 2 inhibitors and nephrolithiasis risk in patients with type 2 diabetes
Paik JM, Tesfaye H, Curhan GC, et al.
JAMA Intern Med. Pub. online 29 Jan 2024.
Leggi
Paik JM, Tesfaye H, Curhan GC, et al.
JAMA Intern Med. Pub. online 29 Jan 2024.
Leggi
Kovatchev BP, Frasquet AC, Pryor EC, et al.
Diabetes Technol Ther. Pub. online 26 Jan 2024.
Leggi
Sebastian-Valles F, Martínez-Alfonso J, Arranz Martin JA, et al.
BMC Med. 2024;22(1):37.
Leggi
Cherrington AL, Bebu I, Krause-Steinrauf H, et al.
Diabetes Care. 2024: dc230642.
Leggi
Gilliam LK, Parker MM, Moffet HH, et al.
Diabetes Technol Ther. Pub. online 26 Jan 2024.
Leggi
Linea Guida della Associazione dei Medici Diabetologi (AMD), della Società Italiana di Diabetologia (SID) e della Società Italiana di Endocrinologia e Diabetologia Pediatrica (SIEDP)
Aggiornamento SNLG-ISS. 29/01/2024
Leggi
American Diabetes Association Professional Practice Committee
Diabetes Care 2024;47(Suppl. 1):S5–S10.
Leggi
Hope DCD, Ansari S, Choudhury S, et al.
Diabetes Obes Metab. Pub. online 16 Jan 2024.
Leggi
Wei X, Hu J, Wen D
BMC Pregnancy Childbirth. Pub. online 23 Jan 2024.
Leggi
Banerji MA, Buse JB, Younes N, et al.
Diabetes Care. dc231356.
Leggi